In May 2019, yuankanglai biotechnology (shenzhen) co., LTD was established
In May 2019, weidong group appointed professor li yuxin, director of the national engineering laboratory, as its chief scientist
April 2019
In April 2019, weidong Taiwan yuankanglai biotechnology co., LTD was established in Taiwan
In April 2019, we cooperated with the third people's hospital of shenzhen to carry out the clinical trial project of fat stem cell therapy for type 2 diabetes
In April 2019, the company reached cooperation with the biomedical industry and hospital laboratories of Qingdao municipal hospital.
March 2019
In March 2019, weidong biological laboratory started construction of AABB laboratory conforming to international standards
December 2018
In December 2018, we acquired guangzhou zhuangshiwei group for integrated operation and opened the cell market in south China.
May 2014
In May 2014, weidong biology held the public welfare activity of "purple ribbon"
